Last reviewed · How we verify
Testosterone and Alendronate in Hypogonadal Men
This study will investigate the hypothesis that the combination of testosterone replacement and alendronate will improve bone density and parameters of bone quality more than either medication alone in older men with low testosterone levels and low bone density.
Details
| Lead sponsor | Massachusetts General Hospital |
|---|---|
| Phase | Phase 2 |
| Status | TERMINATED |
| Enrolment | 44 |
| Start date | 2011-10 |
| Completion | 2014-12 |
Conditions
- Hypogonadism
- Osteopenia
- Osteoporosis
Interventions
- Testosterone
- Alendronate
- Placebo Alendronate
- Placebo Testosterone
Primary outcomes
- Percent Change in Spine Bone Density From Baseline to 12 Months — Baseline and 12 months
Percent Change in Spine Bone Density from Baseline (month 0) to Month 12
Countries
United States